Your browser doesn't support javascript.
loading
Addition of Peptide Receptor Radiotherapy to Immune Checkpoint Inhibition Therapy Improves Outcomes in Neuroendocrine Tumors.
Esfahani, Shadi A; De Aguiar Ferreira, Carolina; Summer, Priska; Mahmood, Umar; Heidari, Pedram.
Affiliation
  • Esfahani SA; Athinoula A. Martinos Center for Biomedical Imaging, Department of Radiology, Massachusetts General Hospital, Charlestown, Massachusetts.
  • De Aguiar Ferreira C; Institute for Innovation in Imaging, Massachusetts General Hospital, Boston, Massachusetts; and.
  • Summer P; Division of Nuclear Medicine and Molecular Imaging, Department of Radiology, Massachusetts General Hospital, Boston, Massachusetts.
  • Mahmood U; Athinoula A. Martinos Center for Biomedical Imaging, Department of Radiology, Massachusetts General Hospital, Charlestown, Massachusetts.
  • Heidari P; Athinoula A. Martinos Center for Biomedical Imaging, Department of Radiology, Massachusetts General Hospital, Charlestown, Massachusetts.
J Nucl Med ; 64(7): 1056-1061, 2023 07.
Article in En | MEDLINE | ID: mdl-37024303
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Organometallic Compounds / Neuroendocrine Tumors Type of study: Prognostic_studies Limits: Animals / Humans Language: En Journal: J Nucl Med Year: 2023 Type: Article
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Organometallic Compounds / Neuroendocrine Tumors Type of study: Prognostic_studies Limits: Animals / Humans Language: En Journal: J Nucl Med Year: 2023 Type: Article